한림대학교성심병원

김호영 교수

031-380-3704 ksfamily@hallym.or.kr
  • 진료과 혈액종양내과

전문진료분야

유방암 및 폐암, 비뇨기/부인과종양, 악성흑색종 및 육종, 피부암, 일반 혈액질환(골수증식성질환, 빈혈 및 혈소판 질환 등)

전화 예약 1577-1801
교수님사진

(주간) 진료시간표 (2021-11-29 ~ 2021-12-04)

진료시간표
진료시간
오전 외래진료외래진료
오후 외래진료센터진료외래진료
교수님 사진

기본정보

학력

학력

연세대학교 원주캠퍼스 의과대학 졸업

아주대학교 의과대학 석사

연세대학교 의과대학 박사

경력

경력

삼성서울병원 연구강사

현) 한림대학교성심병원 혈액종양내과 교수

연세대학교 원주캠퍼스 의과대학 조교수

학회활동

학회활동

대한혈액학회 정회원

대한종양내과학회 정회원

대한암학회 정회원

논문

A Novel Pathogenic CALR Exon 9 Mutation in a Patient with Essential Thrombocythemia (LABORATORY MEDICINE)

Novel genes exhibiting DNA methylation alterations in Korean patients with chronic lymphocytic leukaemia: a methyl-CpG-binding domain sequencing study (SCIENTIFIC REPORTS)

BRAF and NRAS mutations and antitumor immunity in Korean malignant melanomas and their prognostic relevance: Gene set enrichment analysis and CIBERSORT analysis (Pathology Research and Practice)

First Report of a Patient With Natural Killer-Lymphoblastic Leukemia/Lymphoma in Korea (Annals of Laboratory Medicine)

Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus$$cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective$$analysis: KCSG GU 17-03 (Cancer Med)

Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in ALK-positive$$lung cancer: Comparison with EGFR-mutated lung cancer (Pathol Res Pract)

Clinical implications of TERT promoter mutation on IDH mutation andMGMT promoter methylation in diffuse gliomas (Pathology - Research and Practice)

Pazopanib for the Treatment of Non-Clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study. / ^^영문 제목을 반드시 기재하시기 바랍니다. (Cancer Res Treat)

Invasion Depth Measured in Millimeters is a Predictor of Survival in Patients with Distal Bile Duct Cancer: Decision Tree Approach (WORLD JOURNAL OF SURGERY)

Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08 (CANCER RESEARCH AND TREATMENT)